Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IGURATIMOD Cause Disseminated intravascular coagulation? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Disseminated intravascular coagulation have been filed in association with IGURATIMOD. This represents 1.8% of all adverse event reports for IGURATIMOD.

5
Reports of Disseminated intravascular coagulation with IGURATIMOD
1.8%
of all IGURATIMOD reports
2
Deaths
5
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From IGURATIMOD?

Of the 5 reports, 2 (40.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IGURATIMOD. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does IGURATIMOD Cause?

Interstitial lung disease (26) Pneumocystis jirovecii pneumonia (20) Pneumonia bacterial (13) Off label use (12) Pneumonia (10) Covid-19 (9) Lymphoproliferative disorder (9) Stomatitis (9) Condition aggravated (8) Hepatic function abnormal (8)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Which IGURATIMOD Alternatives Have Lower Disseminated intravascular coagulation Risk?

IGURATIMOD vs ILOPERIDONE IGURATIMOD vs ILOPROST IGURATIMOD vs IMATINIB IGURATIMOD vs IMBRUVICA IGURATIMOD vs IMDEVIMAB

Related Pages

IGURATIMOD Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation IGURATIMOD Demographics